Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance

Omar Asghar, Ioannis N Petropoulos, Uazman Alam, Wendy Jones, Maria Jeziorska, Andrew Marshall, Georgios Ponirakis, Hassan Fadavi, Andrew J M Boulton, Mitra Tavakoli, Rayaz A Malik, Omar Asghar, Ioannis N Petropoulos, Uazman Alam, Wendy Jones, Maria Jeziorska, Andrew Marshall, Georgios Ponirakis, Hassan Fadavi, Andrew J M Boulton, Mitra Tavakoli, Rayaz A Malik

Abstract

Objective: Impaired glucose tolerance (IGT) represents one of the earliest stages of glucose dysregulation and is associated with macrovascular disease, retinopathy, and microalbuminuria, but whether IGT causes neuropathy is unclear.

Research design and methods: Thirty-seven subjects with IGT and 20 age-matched control subjects underwent a comprehensive evaluation of neuropathy by assessing symptoms, neurological deficits, nerve conduction studies, quantitative sensory testing, heart rate variability deep breathing (HRVdb), skin biopsy, and corneal confocal microscopy (CCM).

Results: Subjects with IGT had a significantly increased neuropathy symptom profile (P < 0.001), McGill pain index (P < 0.001), neuropathy disability score (P = 0.001), vibration perception threshold (P = 0.002), warm threshold (P = 0.006), and cool threshold (P = 0.03), with a reduction in intraepidermal nerve fiber density (P = 0.03), corneal nerve fiber density (P < 0.001), corneal nerve branch density (P = 0.002), and corneal nerve fiber length (P = 0.05). No significant difference was found in sensory and motor nerve amplitude and conduction velocity or HRVdb.

Conclusions: Subjects with IGT have evidence of neuropathy, particularly small-fiber damage, which can be detected using skin biopsy and CCM.

© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Figures

Figure 1
Figure 1
Skin punch biopsy specimens immunostained for PGP9.5 (A and B) and CCM images (C and D) from a healthy control subject vs. a subject with IGT. The graphs show the distribution of CNFD (E), CNBD (F), and CNFL (G) in control subjects vs. IGT subjects. In C compared with D, a significant reduction in corneal nerve fibers (yellow arrows) and nerve branches (red arrows) is observed, which mirrors the reduction in the same subject in intraepidermal nerve fibers (yellow arrows) reaching the upper levels of epidermis in B compared with A. The subepidermal nerve plexus is also visible (purple arrowhead). Data points in E, F, and G represent actual corneal subbasal nerve parameters in control subjects (n = 20) vs. IGT subjects (n = 37). The purple dashed lines represent group averages, and the blue dashed line in E represents a cutoff for “risk of neuropathy” (IGTN).

References

    1. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001;24:1448–1453
    1. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol 1990;131:633–643
    1. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, KORA Study Group . Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med 2009;10:393–400
    1. Dyck PJ, Clark VM, Overland CJ, et al. . Impaired glycemia and diabetic polyneuropathy: the OC IG Survey. Diabetes Care 2012;35:584–591
    1. Smith AG, Russell J, Feldman EL, et al. . Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006;29:1294–1299
    1. Petropoulos IN, Alam U, Fadavi H, et al. . Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy. Invest Ophthalmol Vis Sci 2014;55:2071–2078
    1. Breiner A, Lovblom LE, Perkins BA, Bril V. Does the prevailing hypothesis that small-fiber dysfunction precedes large-fiber dysfunction apply to type 1 diabetic patients? Diabetes Care 2014;37:1418–1424
    1. Tavakoli M, Mitu-Pretorian M, Petropoulos IN, et al. . Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes 2013;62:254–260
    1. Petropoulos IN, Manzoor T, Morgan P, et al. . Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology. Cornea 2013;32:e83–e89
    1. Ziegler D, Papanas N, Zhivov A, et al. for the GDS Group . Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 2014;63:2454–2463
    1. Dyck PJ, Kratz KM, Karnes JL, et al. . The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817–824
    1. Isak B, Oflazoğlu B, Tanrıdag T, Yitmen I, Us O. Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev 2008;24:563–569
    1. Malik RA. Why are there no good treatments for diabetic neuropathy? Lancet Diabetes Endocrinol. 16 April 2014 [Epub ahead of print]

Source: PubMed

3
購読する